The Latest Breaking News from JNJ

The Fed’s aggressive monetary policy stance created immense recession fear until the inflation showed signs of cooling down in October, and the policymakers hinted at a slower pace of rate hikes. Amid such an uncertain macroeconomic scenario, investors could consider buying safe-haven stocks Johnson & Johnson (JNJ), The Coca-Cola Company…

The Fed might be on course to trigger market volatility with another interest rate hike next month. With an end to the Fed’s campaign on inflation through rate hikes nowhere in sight, it would be wise to invest in resilient stocks Microsoft (MSFT), Johnson & Johnson (JNJ), and Coca-Cola (KO),…

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

Although October CPI data came in lower than expected, inflation is still hovering at an uncomfortably high level. As the Fed is expected to maintain its hawkish stance to control such high inflation, the economy could witness a recession next year. Hence, it could be wise to invest in defensive…

Leading healthcare company Johnson & Johnson (JNJ) has been able to navigate the volatile market conditions due to the defensive nature of its business and solid fundamentals. Moreover, the company has an impressive history of increasing its dividends. Given JNJ’s robust financials, high profitability, and consistent dividend payouts, we think…

Despite the October inflation report showing a slowdown in the price increases, the U.S. economy is still surrounded by deep uncertainty. Moreover, the IMF has warned of further challenges ahead. Therefore, quality stocks Johnson & Johnson (JNJ) and Coca-Cola (KO), which have a solid dividend-paying record, could be ideal additions…

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The World Bank has warned about a global recession next year. Moreover, although the October inflation report shows signs of cooling price pressures, inflation is still far from the Fed’s target level. Hence, we believe fundamentally solid dividend-paying stocks Johnson & Johnson (JNJ) and McDonald’s Corporation (MCD) could be ideal…

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

While inflation remains a major concern, Goldman Sachs’ top economist still sees the chances of the economy avoiding a recession. However, amid prevailing uncertainties, we think fundamentally strong stocks Johnson & Johnson (JNJ), Volkswagen (VWAGY), Stellantis (STLA), and Core Molding Technologies (CMT) might be worth adding to your portfolio. Continue…

The Fed’s continued hawkish stance has kept the stock market under tremendous pressure. However, a cooling labor market may indicate some slowdown in rate hikes. Amid this scenario, we think investors might consider buying fundamentally solid stocks, Johnson & Johnson (JNJ) and Waste Management (WM). Read on….